PerkinElmer Inc. expanded its reach in Asia, acquiring an Indian genetic testing firm for an undisclosed amount and spending $64 million on a Shanghai-based diagnostic supplies provider.
The Waltham, Mass.-based devices and diagnostics giant said it bought Chennai, India-based Surendra Genetic Labs Pvt Ltd., which provides testing services for pregnant mothers and newborns.
The purchase will be folded into PerkinElmer’s genetic screening business, according to division president Ann-Christine Sundell.
The company also said it bought Chinese infectious disease diagnostics instrument and reagent supplier SYM-BIO Lifescience for about $63.7 million in cash.
PerkinElmer said the deal doubles its access to the hospital market in China, along with a significant diagnostics manufacturing and R&D base. And, like the Surendra deal, it’s an opportunity to expand its prenatal and newborn screening business in China.